GenKOre Announces Strategic Collaboration With Revvity to Develop Innovative Gene Therapy Treatments

GenKOre, a pioneer in gene editing technology with its proprietary hypercompact CRISPR, known as TaRGET, is pleased to announce a strategic...

PR NewswireJun 18 12:00 ET

At US$107, Is It Time To Put Revvity, Inc. (NYSE:RVTY) On Your Watch List?

Today we're going to take a look at the well-established Revvity, Inc. (NYSE:RVTY). The company's stock received a lot of attention from a substantial price movement on the NYSE over the last few

Simply Wall StJun 18 08:57 ET

Revvity(RVTY.US) Officer Sells US$441.84K in Common Stock

$Revvity(RVTY.US)$ Officer Goldberg Joel S sold 4,000 shares of common stock on Jun 7, 2024 at an average price of $110.46 for a total value of $441.84K.Source: Announcement What is statement of chang

moomoo NewsJun 10 16:51 ET

Form 144 | Revvity(RVTY.US) Officer Proposes to Sell 441.2K in Common Stocks

SEC FILLINGS DISCLOSED/ Jun 7, $Revvity(RVTY.US)$ Officer Goldberg Joel S intends to sell 4,000 shares of its common stock on Jun 7, with a total market value of approximately $441.2K. Source: Anno

moomoo NewsJun 7 10:22 ET

Optimism Around Revvity (NYSE:RVTY) Delivering New Earnings Growth May Be Shrinking as Stock Declines 4.4% This Past Week

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market index fund. But its virtually certain that sometimes you will buy stocks that fall

Simply Wall StMay 31 07:09 ET

Reasons to Retain Revvity (RVTY) Stock in Your Portfolio Now

Yahoo FinanceMay 30 11:38 ET